From the Journals

AI Scribes: Efficiency for Whom?

Share

The rapid adoption of artificial intelligence scribes in US healthcare systems aims to alleviate documentation burdens, yet their implementation raises significant ethical, clinical, and regulatory concerns. Authors led by Ursula M. Francis, JD, PhD, MSc, emphasize the need for regulatory approval and post-deployment quality checks to ensure safety and efficacy. AI scribes can generate inaccurate notes, risking misrepresentation of patient information and undermining trust. Concerns with bias, privacy, and overcapture highlight the need for robust oversight and standardized evaluation metrics to improve these tools and align them with healthcare goals.

Original Source(s)

Related Content